19.02.2013 Views

solvay_live243_p02a04 somEdito

solvay_live243_p02a04 somEdito

solvay_live243_p02a04 somEdito

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Dossier<br />

105061<br />

44<br />

VIRTUAL SERVER PROJECT SAVES TIME<br />

AND MONEY FOR INTERNAL CUSTOMERS<br />

AT SOLVAY PHARMACEUTICALS<br />

A VIRTUAL SERVER<br />

FOR TANGIBLE GAINS<br />

SolvayInnovationTrophy2006<br />

As a general rule, the development<br />

of a new IT application implies the<br />

acquisition and configuration of new servers<br />

(up to three in fact: development, test,<br />

production) in order to guarantee the total<br />

isolation of the existing application so<br />

as not to threaten its integrity. The<br />

innovation consists of “virtualising” part of<br />

an existing server, that is, isolating one part<br />

and endowing it with all the functions of a<br />

completely autonomous server, for the<br />

applications or development. This operation<br />

has been applied at Marietta (US),<br />

with runaway success. The virtualisation<br />

of servers allows the creation of an IT<br />

environment for a new application within<br />

hours, rather than weeks, for a fraction<br />

of the cost of real servers.<br />

At Marietta alone, 91 virtual servers are<br />

in operation on only 8 real machines, which<br />

amounts to a reduction factor of 11.<br />

The setting up of virtual servers is now in<br />

progress in other Solvay Pharmaceuticals<br />

sites, Weesp (Netherlands), Hanover<br />

(Germany) and for the 3S project.<br />

> Scott Fouche; Ron Criswell; Mike Gerety;<br />

Earl Hartsell; Bruce Mc Millan; Fabian Gonzalez;<br />

Ruben Gabbarrini.<br />

> PHARMACEUTICALS SECTOR<br />

105043<br />

IMPROVED PROCESS TO TAB<br />

USING “GREEN CHEMISTRY”<br />

PRODUCE TAB CHEAPER<br />

AND WITHOUT RESIDUES<br />

TAB (tert-amylbenzene) is the basic raw<br />

material that goes into the production<br />

of amylantraquinone (AQ), itself an<br />

intermediary material for the production<br />

of Hydrogen Peroxyde (H202). Solvay, the<br />

world-wide leader in the production of TAB,<br />

AQ and H202, produces the TAB and AQ<br />

in its Linne Herten plant in the Netherlands.<br />

The demand for TAB is growing, in fact, it<br />

will double in five years’ time following the<br />

construction of new H202 production units,<br />

but the capacity at Linne Herten is saturated.<br />

The current TAB process suffers from several<br />

weaknesses: the use of hazardous<br />

substances, complexity and a large quantity<br />

of waste. The aim of the Solvay team, with<br />

the help of the KUL university of Louvain,<br />

was to develop a new organic synthesis<br />

of TAB without using nor benzene<br />

(carcinogenic) nor BF3 (highly toxic) but<br />

instead using ordinary raw materials, with<br />

a minimum of waste, a simplified reactor<br />

and more effective catalyst. The results are<br />

excellent: the new process uses green<br />

chemistry and is much more economical.<br />

The innovation is based on a new organic<br />

synthesis method and a “super basic<br />

“catalyser. It will reinforce Solvay’s cost<br />

leadership position with regard to its Chinese<br />

competitors. The installation will be up and<br />

running in September 2006 in Jemeppe<br />

(Belgium). In the meantime, a major contract<br />

for the sale of TAB has already been<br />

concluded with a Japanese company that will<br />

buy 100% of its needs from Solvay during<br />

a five years period.<br />

> Armin Liebens; Cyril Ausloos; Stephenhamer<br />

Bloomfield; Gilles Darago; Paul Deschrijver; Bernard<br />

Douillet; Jean-Pierre Ganhy; Bart Vercruysse.<br />

> SBU H 2 O 2<br />

105132<br />

HELLAS – ELECTRONIC LABORATORY NOTEBOOK<br />

THE USER-FRIENDLINESS<br />

OF PAPER, THE POWER<br />

OF ELECTRONICS<br />

The traditional paper laboratory notebooks<br />

are reaching to their limits: the difficulty<br />

of finding detailed information again,<br />

of rereading it, loss of information as a result<br />

of staff rotation, wasted duplication<br />

of experiments, etc.<br />

The “Chemical Development” departments<br />

in Weesp (Netherlands) have found an ideal<br />

solution, an electronic management system<br />

for chemical experiments in laboratories.<br />

By recording everything electronically in the<br />

same format, HELLAS (Human-friendly<br />

Electronic Laboratory Application System)<br />

pools all the information, all the knowledge<br />

on the projects underway, from the basic<br />

organic data, the analytical data,<br />

the molecular structures, to the experimental<br />

details, thus creating a “chemical memory”,<br />

accessible to all researchers. HELLAS is an<br />

internal development, based on software<br />

designed for the field of chemistry<br />

and that puts the emphasis on user-friendliness,<br />

both for data capture and for the<br />

information search via multiple keys. HELLAS<br />

contributes not only to the quality<br />

and reliability of data, but also to the improved<br />

management of all the projects, with,<br />

for example, the automatic generation of the<br />

experiment numbers, experiment reviews,<br />

project reviews... HELLAS has even brought<br />

about an improvement in multifunctional<br />

teamwork. The setting up of HELLAS has<br />

proved to be easy and fast. Four weeks was<br />

all it took. This system is already attracting<br />

interest from other departments, which have<br />

taken steps in this same direction.<br />

> Marcel Vanaar; Kees Bakker; Niek Buizer;<br />

Dick Doesburg; Jan Hoogendoorn; Hans Troost;<br />

Jacques Vanmelis.<br />

> PHARMACEUTICALS SECTOR

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!